Pages

Friday, May 23, 2014

Pluristem Receives Clearance from South Korea to Use PLX Cells...

Pluristem Therapeutics Inc ., a leading developer of placenta-based cell therapies, today announced the latest advancement in its clinical and commercial development programs in South Korea.

http://ift.tt/1gW5ojG

No comments:

Post a Comment